İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2002 · article

Erytropoietin Prevents Motor Neuron Apoptosis and Neurological Disability in Experimental Spinal Cord Ischemic Injury

YÖKSİS OpenAlex Açık erişim · green Üst %1
Yıl2002
Atıf472OpenAlex
Yüzdelik%99,5
FWCI17,471,00 = dünya ortalaması
Scopus (SJR)Q1
WoS (JCR)Q1

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  • Katalog eşleşmesi (ISSN)Proceedings of the National Academy of Sciences of the United States of America
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex İngilizce

The cytokine erythropoietin (EPO) possesses potent neuroprotective activity against a variety of potential brain injuries, including transient ischemia and reperfusion. It is currently unknown whether EPO will also ameliorate spinal cord injury. Immunocytochemistry performed using human spinal cord sections showed abundant EPO receptor immunoreactivity of capillaries, especially in white matter, and motor neurons within the ventral horn. We used a transient global spinal ischemia model in rabbits to test whether exogenous EPO can cross the blood-spinal cord barrier and protect these motor neurons. Spinal cord ischemia was produced in rabbits by occlusion of the abdominal aorta for 20 min, followed by saline or recombinant human (rHu)-EPO (350, 800, or 1,000 units/kg of body weight) administered intravenously immediately after the onset of reperfusion. The functional neurological status of animals was better for rHu-EPO-treated animals 1 h after recovery from anesthesia, and improved dramatically over the next 48 h. In contrast, saline-treated animals exhibited a poorer neurological score at 1 h and did not significantly improve. Histopathological examination of the affected spinal cord revealed widespread motor neuron injury associated with positive terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling in control but not in rHu-EPO-treated animals. These observations suggest both an acute as well as a delayed beneficial action of rHu-EPO in ischemic spinal cord injury. Because rHu-EPO is currently used widely with an excellent safety profile, clinical trials evaluating its potential to prevent motor neuron apoptosis and the neurological deficits that occur as a consequence of ischemic injury are warranted.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

472atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 99 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2003 Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivoAtıf 439 · OpenAlex
  2. 2003 Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivoAtıf 438 · OpenAlex
  3. 2003 Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivoAtıf 436 · OpenAlex
  4. 2002 Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord traumaAtıf 393 · OpenAlex
  5. 2005 Brain‐derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK‐1/‐2 and Akt pathwaysAtıf 231 · OpenAlex
  6. 2005 Brain derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK 1 2 and Akt pathwaysAtıf 230 · OpenAlex
  7. 2004 Erythropoietin and the nervous systemAtıf 180 · OpenAlex
  8. 2003 Neuroprotective Effect of Erythropoietin on Hypoxic Ischemic Brain Injury in Neonatal RatsAtıf 160 · OpenAlex
  9. 2003 Neuroprotective Effect of Erythropoietin on Hypoxic Ischemic Brain Injury in Neonatal RatsAtıf 160 · OpenAlex
  10. 2003 Neuroprotective Effect of Erythropoietin on Hypoxic Ischemic Brain Injury in Neonatal RatsAtıf 160 · OpenAlex

Yazarlar

11
  1. M ÇELİK 1
  2. ALİ NECATİ GÖKMEN 2
  3. REŞAT SERHAT ERBAYRAKTAR DOKUZ EYLÜL ÜNİVERSİTESİ 3
  4. MUSTAFA AKHİSAROĞLU 4
  5. S KONAKÇI 5
  6. EMİNE ÇAĞNUR ULUKUŞ 6
  7. ŞERMİN GENÇ 7
  8. KEMAL KÜRŞAD GENÇ 8
  9. EMEL SAĞIROĞLU 9
  10. ANTHONY CERAMİ 10
  11. MICHAEL BRINES 11